KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Clorox (CLX) over the last 16 years, with Q4 2025 value amounting to -$38.0 million.

  • Clorox's Change in Receivables fell 29000.0% to -$38.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $53.0 million, marking a year-over-year increase of 45333.33%. This contributed to the annual value of $145.0 million for FY2025, which is 32647.06% up from last year.
  • Per Clorox's latest filing, its Change in Receivables stood at -$38.0 million for Q4 2025, which was down 29000.0% from -$118.0 million recorded in Q3 2025.
  • Clorox's Change in Receivables' 5-year high stood at $216.0 million during Q2 2025, with a 5-year trough of -$118.0 million in Q3 2025.
  • Moreover, its 5-year median value for Change in Receivables was $15.0 million (2023), whereas its average is $5.5 million.
  • The largest annual percentage gain for Clorox's Change in Receivables in the last 5 years was 110000.0% (2025), contrasted with its biggest fall of 29000.0% (2025).
  • Clorox's Change in Receivables (Quarter) stood at -$84.0 million in 2021, then soared by 82.14% to -$15.0 million in 2022, then soared by 720.0% to $93.0 million in 2023, then plummeted by 78.49% to $20.0 million in 2024, then plummeted by 290.0% to -$38.0 million in 2025.
  • Its Change in Receivables stands at -$38.0 million for Q4 2025, versus -$118.0 million for Q3 2025 and $216.0 million for Q2 2025.